L-007(Shanghai Jianxin)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameL-007(Shanghai Jianxin)

Drug Alias NameL-007

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusIND

Highest Status in ChinaN/A

Originator CompaniesL&L Biopharma Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesL&L Biopharma Co Ltd

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A